FRANKFURT, May 7 (Reuters) - German drug manufacturer Stada could return to the stock market as soon as after the summer if bids are not high enough in a possible sale sought by its owners ...

FRANKFURT, March 17 (Reuters) - German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the matter said, in a test for Europe's ...

Stada is postponing its initial public offering in Germany, the latest IPO candidate to put plans to go public on hold after U.S. President Trump’s tariff blitz rattled markets globally. The ...

FRANKFURT (Reuters) -German pharmaceuticals company Stada has postponed a planned initial public offering (IPO) in Frankfurt because of market volatility, two people familiar with the matter told ...

Stada will postpone its planned initial public listing on the Frankfurt stock exchange as a result of U.S. tariffs, market volatility and geopolitical uncertainties. The German healthcare company ...

Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are taking place. Peter ...

Stada Arzneimittel AG is sounding out investors for its initial public offering that could potentially raise around €1.5 billion ($1.6 billion) of fresh capital for the consumer health-focused ...

At the turn of the year, STADA's owners Cinven and Bain Capital are setting the course for the future. No decision has yet been taken; various options are under consideration, including an initial ...